PICC Capital
人保资本
elsewhere's corpus does not cover PICC Capital as a subject in its own right. The only material naming it is a set of 2022 funding announcements in which PICC Capital appears as a co-lead investor, alongside China Life Equity, in two consecutive rounds totaling $150 million for METiS Pharmaceuticals . No founding date, fund size, strategy, or team details are provided in these references.
AI-generated — may contain errors, please verify.
PICC CapitalCompany
人保资本
渲染中…
Mentioned in 3 articles
Coverage
2022, the Door Opens to the Future | 5Y News Monthly
The big news from last month.
5Y News | Vastai Technologies Completes Two Consecutive Rounds of Series B-1 and B-2 Funding, Raising 1.6 Billion RMB
5Y Capital has been closely following the development of China's AI sector.
Morningside-backed XtalPi raises over $300 million in new funding | Light Moments
5Y Capital has long been bullish on the application of computational science in the life sciences, hoping that the convergence of IT and biotechnology will soon usher human health into a new era.
